Antianemia Drug Receives Boxed WarningAschenbrenner, Diane S. MS, RNAJN, American Journal of Nursing: August 2015 - Volume 115 - Issue 8 - p 48 doi: 10.1097/01.NAJ.0000470402.36306.54 Drug Watch Buy Abstract Author InformationAuthors Article MetricsMetrics A new boxed warning and a new contraindication are being added to the labeling of ferumoxytol (Feraheme). The boxed warning states that there is a risk of anaphylaxis and even death with ferumoxytol infusion. The new contraindication to use is a previous allergic reaction to ferumoxytol or any other IV iron-replacement drug. Diane S. Aschenbrenner was previously the course coordinator for undergraduate pharmacology at Johns Hopkins University School of Nursing in Baltimore, MD. She also coordinates Drug Watch: email@example.com. Copyright © 2015 Wolters Kluwer Health, Inc. All rights reserved.